Acutaas Chemical

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE00FF01025
  • NSEID: ACUTAAS
  • BSEID: 543349
INR
1,705.00
-6.1 (-0.36%)
BSENSE

Dec 05

BSE+NSE Vol: 1.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Net Sales
1,006.88
717.47
616.73
520.14
340.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,006.88
717.47
616.73
520.14
340.61
Raw Material Cost
569.81
440.17
345.85
282.33
174.69
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-17.63
-28.48
-14.96
-9.50
4.81
Employee Cost
83.66
63.11
48.84
41.37
21.01
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
138.96
114.18
114.39
100.75
59.94
Total Expenditure (Excl Depreciation)
774.80
588.98
494.13
414.96
260.45
Operating Profit (PBDIT) excl Other Income
232.08
128.49
122.60
105.18
80.16
Other Income
16.93
7.49
4.32
2.76
1.38
Operating Profit (PBDIT)
249.01
135.98
126.92
107.94
81.54
Interest
6.22
5.94
2.41
6.41
5.62
Exceptional Items
0.00
-32.08
0.00
0.00
0.00
Gross Profit (PBDT)
242.79
97.96
124.51
101.53
75.92
Depreciation
26.62
16.06
12.34
10.08
4.19
Profit Before Tax
216.16
81.90
112.17
91.45
71.73
Tax
55.75
33.19
28.88
19.50
17.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
160.42
48.71
83.29
71.95
54.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
160.42
48.71
83.29
71.95
54.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.70
-5.94
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
158.71
42.77
83.29
71.95
54.00
Equity Capital
40.93
36.88
36.44
36.44
31.50
Face Value
5.0
10.0
10.0
10.0
10.0
Reserves
1,268.69
637.12
557.52
485.84
135.43
Earnings per share (EPS)
9.69
5.8
22.86
19.74
17.14
Diluted Earnings per share
9.9
5.83
22.86
21.03
17.14
Operating Profit Margin (Excl OI)
23.05%
17.91%
19.88%
20.22%
23.53%
Gross Profit Margin
24.11%
13.65%
20.19%
19.52%
22.29%
PAT Margin
15.93%
6.79%
13.51%
13.83%
15.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 40.34% vs 16.33% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 271.08% vs -48.65% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 80.62% vs 4.80% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 4.71% vs 146.47% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Acutaas Chemical With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,006.88
1,937.47
-930.59
-48.03%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,006.88
1,937.47
-930.59
-48.03%
Raw Material Cost
569.81
248.45
321.36
129.35%
Purchase of Finished goods
0.00
575.70
-575.70
-100.00%
(Increase) / Decrease In Stocks
-17.63
-53.31
35.68
66.93%
Employee Cost
83.66
177.72
-94.06
-52.93%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
138.96
341.98
-203.02
-59.37%
Total Expenditure (Excl Depreciation)
774.80
1,290.54
-515.74
-39.96%
Operating Profit (PBDIT) excl Other Income
232.08
646.93
-414.85
-64.13%
Other Income
16.93
96.43
-79.50
-82.44%
Operating Profit (PBDIT)
249.01
743.36
-494.35
-66.50%
Interest
6.22
0.61
5.61
919.67%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
242.79
742.75
-499.96
-67.31%
Depreciation
26.62
65.96
-39.34
-59.64%
Profit Before Tax
216.16
676.79
-460.63
-68.06%
Tax
55.75
135.69
-79.94
-58.91%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
160.42
541.10
-380.68
-70.35%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
160.42
541.10
-380.68
-70.35%
Share in Profit of Associates
0.00
-0.01
0.01
100.00%
Minority Interest
-1.70
-4.78
3.08
64.44%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
158.71
536.31
-377.60
-70.41%
Equity Capital
40.93
15.20
25.73
169.28%
Face Value
5.00
2.00
0.00
Reserves
1,268.69
2,835.29
-1,566.60
-55.25%
Earnings per share (EPS)
9.69
70.57
-60.88
-86.27%
Diluted Earnings per share
9.90
70.25
-60.35
-85.91%
Operating Profit Margin (Excl OI)
23.05%
33.39%
0.00
-10.34%
Gross Profit Margin
24.11%
38.34%
0.00
-14.23%
PAT Margin
15.93%
27.93%
0.00
-12.00%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,006.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.34% vs 16.33% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 158.71 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 271.08% vs -48.65% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 232.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 80.62% vs 4.80% in Mar 2024

Annual - Interest
Interest 6.22 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.71% vs 146.47% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.05%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024